Cargando…
An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic
Clostridium novyi has demonstrated selective efficacy against solid tumors largely due to the microenvironment contained within dense tumor cores. The core of a solid tumor is typically hypoxic, acidic, and necrotic—impeding the penetration of current therapeutics. C. novyi is attracted to the tumor...
Autores principales: | Dailey, Kaitlin M., Small, James M., Pullan, Jessica E., Winfree, Seth, Vance, Krysten E., Orr, Megan, Mallik, Sanku, Bayles, Kenneth W., Hollingsworth, Michael A., Brooks, Amanda E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645340/ https://www.ncbi.nlm.nih.gov/pubmed/37963142 http://dx.doi.org/10.1371/journal.pone.0289183 |
Ejemplares similares
-
Methods and Techniques to Facilitate the Development of Clostridium novyi NT as an Effective, Therapeutic Oncolytic Bacteria
por: Dailey, Kaitlin M., et al.
Publicado: (2021) -
Clostridium novyi-NT in cancer therapy
por: Staedtke, Verena, et al.
Publicado: (2016) -
Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification
por: Shreffler, Jacob W., et al.
Publicado: (2019) -
Acute myonecrosis in horse caused by Clostridium novyi type A
por: Farias, Luana D’avila, et al.
Publicado: (2014) -
The oncolytic activity of Clostridium novyi nontoxic spores in breast cancer
por: Abedi Jafari, Fatemeh, et al.
Publicado: (2022)